Myriad Genetics Inc (MYGN)

Operating Cash Flow (Statement)

$7.70M

TTM · Period ending: · USD

MYGN logo

MYGN Operating Cash Flow (Statement)

Latest reported$7.70M
MYGN TTM Cash from Operations (-$4.30M → $7.70M)
High-resolution chart · PNG

MYGN operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Myriad Genetics Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-3,775,307
-2,470,662
-2,772,002
3,574,875
17,163,535
8,222,000
5,000,000
-1,300,000
-14,100,000
-12,200,000
-12,200,000
-10,900,000
-7,000,000
-2,800,000
-3,900,000
-5,600,000
-6,600,000
-10,800,000
-4,300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.